LYON , France, November 20, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference , taking place November 27-29, 2018 in New York City .
EDAP to Provide Live Demonstrations and Host Q&A with Interested Parties at Booth #2211 LYON , France, April 29, 2019 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it will demonstrate the capabilities of its range of minimally-invasive therapeutic
Houston Methodist's Upgrade from Ablatherm to Focal One Reinforces EDAP's Position as a Leading HIFU Innovator LYON, France , March 4, 2019 -- EDAP TMS SA (Nasdaq: EDAP) -- Houston Methodist Hospital , one of the first hospitals in the U.S. to offer Ablatherm® Robotic High Intensity Focused
AUSTIN, TX - LYON, France , September 26, 2018 - EDAP TMS (Nasdaq: EDAP) today announced the results of a study conducted at Houston Methodist Medical Center in Houston, TX that showed High Intensity Focused Ultrasound (HIFU) to be safe and effective, with oncologic control for prostate cancer
Focal One System Enhances Precision Tissue Ablation, Reduces Side Effects for Prostate Cancer Patients LYON, France -- January 3, 2019 - EDAP TMS SA (Nasdaq: EDAP) today announced that the John Wayne Cancer Institute (JWCI) at the Providence Saint John's Health Center in Santa Monica, CA is the
UC I Health , one of the three US medical centers to acquire EDAP's Focal One device, is a recognized leader in prostate cancer diagnosis and treatment utilizing robot-assisted and minimally invasive technologies LYON, France , February 5 , 2019 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the
Focal One's precision means qualifying prostate cancer patients can forego prostate removal surgery and avoid life-altering side effects including incontinence and impotence LYON, France - April 1, 2019 - EDAP TMS SA (Nasdaq: EDAP) , the global leader in therapeutic ultrasound, today announced that
MONTREAL, QUEBEC - OCTOBER 24, 2018 - Urologists, uro-oncologists and urology department chairs from renowned American universities will spend a day - October 25, 2018 -- at Jewish General Hospital , a McGill University teaching hospital, where they will learn to perform a more precise outpatient
Positions EDAP to Accelerate U.S. Sales and Marketing Expansion for HIFU Strengthens Financial Resources to Grow Global Operations LYON, France , April 14, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced the closing of its previously
Total revenue of EUR 8.7 million ( USD 9.3 million ) for Q1 2017 +16.5% growth in HIFU treatment driven recurring revenues Strong cash position of EUR 20.3 million ( USD 21.7 million ) as of March 31, 2017 CMS Medicare C-code submission for HIFU reimbursement in the U.S.